Literature DB >> 11761740

The role of anxiety and adaptation to illness in the intensity of postchemotherapy nausea in cancer patients.

T Blasco1, C Pallarés, C Alonso, J J López López.   

Abstract

The aim of this work was to assess whether cancer patients presenting high anxiety levels or poor adaptation to cancer experience higher levels of postchemotherapy nausea, regardless of the emetogenicity of the chemotherapy schedule. Sixty-three patients were interviewed before receiving their chemotherapy schedule and some psychological variables were assessed. Nausea intensity was also assessed after treatment. The results showed that patients with relatively higher levels of nausea reported higher levels of anxiety prior to chemotherapy and lower levels of adaptation to cancer. Thus, evidence for a modulating effect of psychological factors in postchemotherapy emesis is suggested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11761740     DOI: 10.1017/s1138741600005539

Source DB:  PubMed          Journal:  Span J Psychol        ISSN: 1138-7416            Impact factor:   1.264


  4 in total

1.  Distress before chemotherapy predicts delayed but not acute nausea.

Authors:  Sara C Higgins; Guy H Montgomery; Dana H Bovbjerg
Journal:  Support Care Cancer       Date:  2006-08-03       Impact factor: 3.603

Review 2.  Integrative review of factors related to the nursing diagnosis nausea during antineoplastic chemotherapy.

Authors:  Aline Maria Bonini Moysés; Lais Corsino Durant; Ana Maria de Almeida; Thais de Oliveira Gozzo
Journal:  Rev Lat Am Enfermagem       Date:  2016-10-10

3.  A Judgement Bias Test to Assess Affective State and Potential Therapeutics in a Rat Model of Chemotherapy-Induced Mucositis.

Authors:  Rebecca P George; Timothy H Barker; Kerry A Lymn; Dylan A Bigatton; Gordon S Howarth; Alexandra L Whittaker
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

4.  Individual Factors Contributing to Nausea in First-Time Chemotherapy Patients: A Prospective Cohort Study.

Authors:  Karin Meissner; Nicola Talsky; Elisabeth Olliges; Carmen Jacob; Oliver J Stötzer; Christoph Salat; Michael Braun; Raluca Flondor
Journal:  Front Pharmacol       Date:  2019-04-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.